Related Experiment Video
Updated: Sep 19, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Plug- Versus Sutured-Based Vascular Closure Devices for Large Bore Arterial Access: A Systematic Review and
Anastasios Apostolos1, Konstantinos Konstantinou1, Nikolaos Ktenopoulos2
1Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippocration General Hospital of Athens, Athens, Greece.
None:
Vascular complications after cardiovascular interventions requiring large-bore arterial access remain frequent and devastating. Whether plug-based vascular closure devices (P-VCD) or sutured-based vascular closure device (S-VCD) are superior in terms of safety and efficacy remains unclear. Aim of our systematic review and meta-analysis was to compare P-VCD with S-VCD. We systematically screened 3 major databases for 2-arm studies comparing P-VCD with S-VCD. Primary endpoint was device success. Secondary endpoints included in-hospital all-cause mortality, major and minor bleeding, major and minor vascular complications, unplanned vascular surgery, endovascular treatment and hospital stay. For categorical variables, we used risk ratios (RRs) with 95% confidence intervals (CIs) and for continuous variables, mean differences or standardized mean differences. A total of 23 studies and 7,584 patients were included in our analysis. No significant differences were observed in device success (RR: 0.98, 95% CI: 0.96 to 1.00, I2 = 62%), all-cause mortality (RR: 0.60, 95% CI: 0.19 to 1.87), major bleedings (RR: 0.68, 95% CI: 0.44 to 1.07), minor bleedings (RR: 0.83, 95% CI: 0.54 to 1.27), major vascular complications (RR: 0.89, 95% CI: 0.56 to 1.42), minor vascular complication (RR: 1.22, 95% CI: 0.82 to 1.83), endovascular treatment (RR: 1.35, 95% CI: 0.79 to 2.29) or unplanned vascular surgery (RR: 1.12, 95% CI: 0.68 to 1.87). However, hospital length of stay was reduced by 0.2 ± 0.13 days in patients treated with P-VCD. In conclusion, our systematic review and meta-analysis, the largest to date, demonstrated no significant differences between P-VCD and S-VCD, regarding safety or efficacy outcomes, except for a shorter hospital stay associated P-VCD. Further studies are required to validate these results.
More Related Videos
07:21Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
Published on: September 8, 2023
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022